Biomarker for forecasting new auxiliary chemotherapy curative effect of breast cancer and fluorescence quantitative immune PCR kit
A biomarker and fluorescence quantitative technology, applied in the field of biomedicine, can solve the problems of NACT insensitivity, delayed local treatment, low pCR rate, etc., and achieve the effect of avoiding blindness
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0068] 20 cases of breast cancer patients without NACT who were treated in Zhejiang Cancer Hospital were punctured to obtain breast cancer tissue samples. Patients were required to have a clear cytological diagnosis, no treatment before surgery, and complete pathological information .
[0069] After the sampling was completed, the patients were given neoadjuvant chemotherapy, and the pCR group and the NpCR group were distinguished according to the curative effect; at the same time, the breast cancer tissue samples were processed as follows:
[0070] 1. Extraction of total RNA from breast cancer tissue
[0071] (1) Total RNA extraction
[0072] 1) In a clean area with less RNase interference (all utensils are wiped with 1‰ DEPC water), the mortar needs to be sterilized at 200°C for 5 hours and cooled for 4 hours. In a mortar pre-cooled with liquid nitrogen, grind to powder with a pestle (incomplete grinding will seriously affect the yield of RNA);
[0073] 2) Add 700 μl of Q...
Embodiment 2
[0112] Fluorescence quantitative PCR analysis of embodiment 2 differentially expressed genes
[0113] For the CCL2 gene, CCR1 gene, CXCL10 gene, CXCL11 gene and IL2RG gene, primer5.0 was used to design fluorescent quantitative PCR primers, and the primer design information is shown in Table 2.
[0114] Table 2 Specific primers for fluorescent quantitative PCR
[0115]
[0116] 2. Real-Time PCR
[0117] 1) Synthesis of the first strand of cDNA
[0118] The total RNA in the tissue was used as a template to carry out reverse transcription reaction to synthesize cDNA.
[0119] Add the following reagents sequentially into a new 200 μl optical PCR eight-tube tube:
[0120]
[0121]
[0122] 2) After mixing, centrifuge slightly and carry out PCR reaction in ABIPRISM7300. The reaction conditions are set as:
[0123] Two-step PCR amplification standard procedure
[0124] Stage1: Pre-denaturation
[0125] Number of cycles: 1
[0126] 95℃30s
[0127] Stage2: PCR reaction...
Embodiment 3
[0138] Embodiment 3 Fluorescent quantitative PCR kit based on SYBRGreen fluorescent dye method
[0139] A fluorescent quantitative PCR kit for predicting the curative effect of neoadjuvant chemotherapy for breast cancer, including the primers shown in Table 2, and reagents such as Taq enzyme and dNTP.
[0140] Using the kit provided in this embodiment, the method of using the fluorescent quantitative PCR detection based on the DNA dye method is as follows:
[0141] In a new 0.2μl optical PCR reaction tube, add in sequence:
[0142]
[0143] The value of this kit lies in the detection of the expression levels of five cytokines and cytokine receptor interaction signaling pathway-related genes by simple DNA dye method through the patient's cancer tissue RNA samples, and then predicting the breast cancer by the degree of difference in the expression levels. The efficacy of NACT in cancer patients, thereby reducing unnecessary treatment. Therefore, the kit is put into producti...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com